Claim

In this real-world case-control study, prior metformin use was not associated with a statistically distinguishable difference in SARS-CoV-2 susceptibility (aOR 0.97, 95% CI 0.81–1.16).

Type QUANTITATIVE · truth-evaluable: yes · status at snapshot: ACTIVE · created seq 15952 · qualifiers {"population":"Population-based case-control study subjects","source_edition":"993d5734-c837-88d0-9417-98c46b2bdaee"}

a comma-separated series may list several propositions

Referenced 101 times: checked 1, looked up by assistants 0, viewed 81, shared 19. A count of attention, not evidence.

Topics

Public health · 1efd24fe Medicine · 1efd24fe

Assessment

Supported

Score: 0.8581 under ledger-default@0.3.0 at snapshot 27745

3 of 4 review checks done · 1 counted · 2 by the author only

1 independent evidence lineage · review checks 1 of 4 · stability MEDIUM

Main unresolved issue: 2 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:3299d500-c492-850f-9d5a-963b4b2edab8

Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.Every quoted passage was confirmed on the page when Galedra fetched it.

Why?

Strongest counted support: The study reports no statistically distinguishable susceptibility difference, with adjusted odds ratio 0.97 and 95% confidence interval 0.81–1.16. weight 1.800000 evidence

Suppressed as dependent: The passage directly reports no susceptibility difference and gives the adjusted odds ratio and confidence interval.

Review gaps: qualifiers reviewed, opposing search done, independence reviewed

What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.

Show calculation

Your view

Registered views

Nobody has registered a view yet.

Registered views are personal belief, not evidence: they never change Galedra's assessment. Affiliations are self-declared and shown only for groups of 5 or more.

Checked as part of

Statements this claim was broken out of. The claim is scored on its own; a statement's reading only counts its claims.

“In a large real-world case-control study, prior metformin use was associated with lower COVID-19 hospitalization and progression odds, but not lower...” · 2 claims · 29 September 2026

Evidence for

The study reports no statistically distinguishable susceptibility difference, with adjusted odds ratio 0.97 and 95% confidence interval 0.81–1.16.

From Metformin use and decreased risk of severe COVID-19 outcomes in a real-world case-control study Read 2026-09-29 Relevance DIRECT Steps 0 Counted
The passage directly reports no susceptibility difference and gives the adjusted odds ratio and confidence interval.

From Metformin use and decreased risk of severe COVID-19 outcomes in a real-world case-control study Read 2026-09-29 Relevance DIRECT Steps 0 Counted

Evidence against

None.

Qualifications

None.

Suppressed as dependent

Evidence	Group	Kept instead
948cabdb		91cf3f85

Inferences

Concluded from

None.

Used as a premise in

None.

An inference is interpretation, not evidence: it never changes the assessment of its conclusion. Each premise is a claim with its own evidence.

Threads

None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.

Claim edges

None. Edges are stored and displayed; v0.1 does not propagate probability across them.

Review checklist

Review checks: 1 of 4

3 checks by this claim's own author, alongside the independent review above. 1 OPPOSING EVIDENCE SEARCH · 1 QUALIFIER CHECK · 1 EVIDENCE VERIFICATION. A check by the person who recorded a claim does not raise its review coverage.

Check	Done	By
qualifiers reviewed	no
opposing search done	no
independence reviewed	no
primary source reviewed	yes	91cf3f85, 079a2027

Summary

Supported. The main support is: The study reports no statistically distinguishable susceptibility difference, with adjusted odds ratio 0.97 and 95% confidence interval 0.81–1.16. 4ea8654c

1 further item repeats the same origin and is not independent evidence. 948cabdb

A search for evidence in the opposing direction found none. aa54156a

Review checks: 1 of 4. coverage:3299d500-c492-850f-9d5a-963b4b2edab8

Generated by stub-v0.1; every sentence cites graph ids.

Contribution history

seq	event	detail
15952	APPENDED
15953	ACCEPT	AUTOMATIC_AFTER_VALIDATION
15962	LINK_EVIDENCE	by 1efd24fe (accepted)
15966	TASK_RESULT	by 1efd24fe (accepted)